RE:Congrats MPH - Great 3rd Quarter - expect $10 to $15 soon
The $105 million dollar purchase price for Apicore is in US Dollars--around $135 million Canadian. The debt, $61 million in total, is 100% Canadian. The purchase was most likely a US co., so there are some extremely favourable exchange rate consequences. On the flip side, Aggrastat is a dead duck...generic Intergrillin, not Aggrastat patent expiration, is going to kill off Agg. The Prexxarten purchase looks good on paper, in acutualiity, it's a liquid generic formulation of an existing generic in pill form...very limited potential. A positive from that acq. is that MPH paid $600k for it, which in the pharma world, is absolutely nothing.